EU ministers criticise patient information plans
This article was originally published in Scrip
Executive Summary
EU member state ministers have welcomed the pharmacovigilance and anti-counterfeiting proposals in the "pharmaceutical package" of draft legislation from the European Commission. But they have again expressed concerns about the proposal to allow pharmaceutical companies to provide drug information directly to patients.